my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Pathogens are continuously emerging and evolving.
Addressing the threat of new and potentially life-threatening pathogens requires deep understanding and accurate, reproducible techniques for developing better tests, vaccines, and treatments.
In these pursuits, every result is time sensitive, and certainty is more crucial than ever.
Agilent provides the complete breadth of systems, consumables, software, services, and knowledge you need to support your success.
Infectious Disease Test Development
Quickly and easily integrate products into your coronavirus research workflows with our reliable, scalable, cost-effective technologies. more
COVID-19 – Infectious Disease Research
When you need to see a true picture of pathogenic response at a cellular level, look to our extensive portfolio of research products and technologies more
COVID-19 & Infectious Disease | When accelerating outcomes with certainty is critical
Pathogens are continuously emerging and evolving. Addressing the threat of new and potentially life-threatening pathogens requires deep understanding more
When exceptional performance meets simplicity
The NovoCyte Penteon flow cytometer builds on its successful predecessor, the NovoCyte, and provides an expanded set of capabilities that accommodate today’s high-end and increasingly sophisticated multi-color flow cytometry assays. You now have the flexibility to choose from up to 30 fluor ... more
Merck Announces Collaboration with Agilent Technologies
Merck announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0. “The biopharmaceutical industry i ... more
Lonza and Agilent Announce Strategic Collaboration
Lonza and Agilent Technologies announced a collaboration that has the potential to transform the way personalized cell therapies are manufactured and realized. Product quality and consistency are significant challenges for cell therapy manufacturing due to the complexity of the products and ... more
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax benefits for Agilent, the net purchase price is expected to be approximately $1.05 billion. The transaction is expected to be compl ... more
Agilent Technologies Sales & Services GmbH & Co. KG
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions and ... more
Agilent Technologies Belgium S.A./N.V.
The world’s premier measurement company When measurement matters, engineers, scientists, manufacturers, businesses, researchers, and government agencies rely on Agilent tools and solutions. From home entertainment to homeland security, from food safety to network reliability, and from comm ... more
Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent’s expertise and trusted collaboration g ... more
© 1997-2022 LUMITOS AG, All rights reserved
breadcrumb_whitepaper
